Facility

The philosophy of Rasayani Biologics believes firmly in capturing the clinical data in a most scientific, ethical and in line with global regulatory requirements.

RBPL has set up a state-of-the-art facility approved under schedule “M” to manufacture active pharmaceutical ingredients and to further formulate them into encapsulated drug products.

The mandate of Cell and Molecular Biology (CMB) Department is to provide support in Pre-Clinical Development Program of the company, in terms of in Vitro and In Vivo Drug Screening.

The Physico-Chemical Department provides analytical support to varied activities of Research and Development like in Vitro / In Vivo Dose Standardization, Pharmacokinetic Studies in Animals and Humans, Clinical Trials.